Mile High Down Syndrome Association Mile High Down Syndrome Association, Inc. (MHDSA) is a non-profit organization which serves families of children and adults with Down syndrome, and interested professionals in the Mountain States region.
MHDSA was formed in 1981 by parents who felt a need to associate more closely with other parents of children with Down syndrome. Support, information, and referral services are provided to over 3,000 callers each year.
MHDSA is currently working with the Eleanor Roosevelt Institute here in Denver on a new research project regarding the cognitive strengths and weaknesses of individuals with Down syndrome. We are affiliated with the National Down Syndrome Congress and the National Down Syndrome Society. |
 |
|
|
 |
|
|
|
|
|
|
|
Our Civitans Volunteer, Donate and Help in sponsoring several events with the MHDSA to include: The Buddy Walk
Breakfast with Santa
Breakfast of Champions To donate to MHDSA Please click on the link Below: https://id307.securedata.net/mhdsa.org/merchantmanager/ |
|
|
|
THE BUDDY WALK The Annual Mile High Down Syndrome Association Buddy Walk broke all previous records for attendance and fundraising, with more than 3,000 people registered to help raise money for Down syndrome advocacy. These generous donations will benefit national education, research and advocacy initiatives, and local programs and services. But more importantly, all the participants helped us spread our messages of acceptance and inclusion of all people with Down syndrome. Those messages will last long after the Buddy Walk! |
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
What is Breakfast of Champions® A joint fundraising event of the Down Syndrome Research Group and the Eleanor Roosevelt Institute at the University of Denver, Breakfast of Champions® benefits Down syndrome research programs and advocacy programs at the Mile High Down Syndrome Association (MHDSA).
Working as a committee of MHDSA, the Down Syndrome Research Group focuses on the importance of research and raises money to fund research that maximizes the ability of people with Down syndrome to lead independent lives by treating the cognitive disabilities and other diseases that disproportionately affect those with Down syndrome. This includes the development of therapies that can reverse or eliminate difficulties with cognition and speech and adulthood decline in neurological function for those with Down syndrome. |
|
|
|
